Emily John on how chimeric antigen receptor T-cell (CAR-T) therapies have transformed outcomes for people with advanced blood cancers.
The post ‘Lived experience tells us about what matters most to patients’ appeared first on Nursing Times.
Emily John on how chimeric antigen receptor T-cell (CAR-T) therapies have transformed outcomes for people with advanced blood cancers.
The post ‘Lived experience tells us about what matters most to patients’ appeared first on Nursing Times.